Affect Therapeutics, Inc.
2 clinical trials · Sponsor
◉ Watch Affect Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Demonstration of a Digital Care Program for Methamphetamine Use Disorder (NCT05206175) | Affect Therapeutics, Inc. | 2022-02-14 |
| Field Study of a Digital Therapeutic Platform to Facilitate Treatment for Methamphetamine-Primary Stimulant Use Disorder (NCT05266716) | Affect Therapeutics, Inc. | 2021-02-18 |
Track Affect Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.